We are live on ! Find out more
GKIM

GW&K Investment Management Portfolio holdings

AUM $12.8B
1-Year Est. Return 48.82%
This Fund
S&P 500
This Quarter Est. Return
+25.52%
1 Year Est. Return
+48.82%
3 Year Est. Return
+110.09%
5 Year Est. Return
+134.03%
10 Year Est. Return
+612.52%
AUM
$9.53B
AUM Growth
+$1.89B
Cap. Flow
+$270M
Cap. Flow %
2.83%
Top 10 Hldgs %
11.36%
Holding
417
New
23
Increased
169
Reduced
161
Closed
41

Sector Composition

Rank Sector Weight
1 Healthcare 17.76%
2 Technology 15.98%
3 Industrials 14.75%
4 Consumer Discretionary 13.32%
5 Financials 12.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORCL icon
401
Oracle
ORCL
$442B
-100
Closed -$6K
PFE icon
402
Pfizer
PFE
$150B
-628
Closed -$22K
PRAA icon
403
PRA Group
PRAA
$737M
$0 ﹤0.01%
12
-382,626
-100% -$15.2M
PRU icon
404
Prudential Financial
PRU
$42.3B
-30
Closed -$2K
SCHD icon
405
Schwab US Dividend Equity ETF
SCHD
$107B
-1,125
Closed -$21K
SNA icon
406
Snap-on
SNA
$21.1B
-20
Closed -$3K
T icon
407
AT&T
T
$166B
-367
Closed -$8K
TXN icon
408
Texas Instruments
TXN
$253B
-96
Closed -$14K
UGI icon
409
UGI
UGI
$7.53B
-187
Closed -$6K
VGSH icon
410
Vanguard Short-Term Treasury ETF
VGSH
$30.2B
-140
Closed -$9K
WGO icon
411
Winnebago Industries
WGO
$915M
-4,301
Closed -$222K
WLYB icon
412
John Wiley & Sons Class B
WLYB
$2.61B
-60
Closed -$2K
WPC icon
413
W.P. Carey
WPC
$16.1B
-41
Closed -$3K
SCTL
414
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
-327,336
Closed -$687K
CMD
415
DELISTED
Cantel Medical Corporation
CMD
-1
Closed
WMGI
416
DELISTED
Wright Medical Group Inc
WMGI
-1,521
Closed -$46K
AIMT
417
DELISTED
Aimmune Therapeutics
AIMT
-295,848
Closed -$10.2M

Similar funds

GW&K Investment Management's Q4 2020 Portfolio in Review

As of Q4 2020, GW&K Investment Management held 417 positions worth $9.53B, up 25% from $7.64B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

GW&K Investment Management's Q4 2020 filing shows 23 new, 169 increased, 161 reduced and 41 closed positions. Its largest new stake was Medpace: 315,843 shares worth $44M. The largest sale was QuidelOrtho, an estimated $67.2M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.

  • GW&K Investment Management's largest Q4 2020 buy was Medpace: 315,843 shares worth $44M.
  • GW&K Investment Management added most to Endava in Q4 2020, an estimated $35.7M increase.
  • GW&K Investment Management's biggest Q4 2020 reduction was QuidelOrtho, cutting an estimated $67.2M.
  • GW&K Investment Management fully exited Aimmune Therapeutics in Q4 2020, selling an estimated $10.2M.
  • GW&K Investment Management's ten largest holdings make up 11% of its $9.53B portfolio in Q4 2020.
  • GW&K Investment Management opened 23 new positions and closed 41 in Q4 2020.
  • GW&K Investment Management's portfolio value rose 25% quarter-over-quarter to $9.53B.

Based on GW&K Investment Management's 13F filing for Q4 2020, filed 5 Feb 2021.